From: A retrospective comparative exploratory study on two Methylentetrahydrofolate Reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients
HR
95% CI
p
R
R0
1.00
0.001
R1/2
3.40
1.7-6.8
Clinical response
yes
0.021
no
10.30
1.4-75.5
MTHFR A1298C
AA
0.028
AC
2.80
1.3-5.9
CC
2.00
0.5-7.6